Sweatman Drug-Drug interactions Flashcards
How the drug affects the body
pharmacodynamics
how the body acts on the drug
pharmacokinetics
(L-ADME)
*lending to means of D-D interactions
1+ 1= 2
additivity
1+1=3
synergism
change in serum blood level
pharmacokinetics
receptor/non-receptor interactions
pharmacodynamics
*lending to means of D-D interactions
many drug-drug interactions are susceptible to control by
dose adjustment
co-admin of cyclosporin with erythromycin has what effect
increases cyclosporin levels and decreases its cost
are all D-D interaction bad
no
some actually beneficial
why are elderly, women and very young at increased risk for ADR’s
decreased capacity to metabolize and excrete drug, normonal changes, immature metobolic mechs etc
*Pharmacokinetics are different than in adults/ men
relationship b/w polypharmacy and incidence
greater number of concurrent drugs being taken–> increases likelihood of ADR’s
*greater drug exposure=greater likelihood of drug-drug interactions
therapeutic window
MTC-MEC
lag period on a dose concentration-time curve indicated
rate of uptake/distribution following adminstration for orally administered drugs
lag time for IV
NONE
duratio of action
time for which the plasma concentration is above the MEC for maximal action upon the recptor
drugs with smaller therapeutic windows are more likely to
exhibit adverse effects
if the plasma concetration remains within the therapeutic window when interacting with a concurrent drug…will it be apparent
NO–> this is why most D-D interaction go unoticed
only when it goes above MTC (toxic) or below MEC (loss of clinical efficacy–>will drug-drug interactions become notiecd
High suspicion of drugs affecting which three categories should be monitored for D-D interactions
- anticoag (thrombosis or hemorrhage)
- Cardiovascular (arrhythmogenic events)
- CNS (ability to cross BBB can cause sedative or seizure activity)
Classifications of Chemical (D-D) interactions
- additive
- synergistic
- potentiation
- antagonism
outcome of physical changes that occur in all of the four chemical interactions
functional changes
chemical changes
dispositional changes
receptor changes
women need lower doses bc
they tend to not clear the drug as rapidly
most common CYP’s
3A4 and 2D6–> expression varies up to 40 fold for 3A4 and these two cyps have MANY different SNP’s
atorvastatin MOA regarding CYP
Enters cell–>binds to nuclear receptor (PXR) which dimerizes with RXR–> binds DNA00> recruits coactivator which binds to TBP at the TATA box–> activates RNA POl II–> upregulates CYP3A4 transcription–> metabolizes Atorvastatin
atorvastatin induces
its OWN metabolism